Stay updated on Nusinersen Safety in SMA Clinical Trial
Sign up to get notified when there's something new on the Nusinersen Safety in SMA Clinical Trial page.
Latest updates to the Nusinersen Safety in SMA Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedMinor editorial updates were added: a PubMed auto-fill note indicating publications may be sourced from PubMed and the revision label updated to v3.3.2, while the older wording and revision v3.2.0 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check19 days agoChange DetectedA general government funding/operating status banner was removed from the page. The study title, design, eligibility criteria, contacts, and locations remain unchanged.SummaryDifference0.3%
- Check33 days agoChange DetectedNo substantial changes were detected in the study details, design, eligibility criteria, or outcomes; the update appears to be minor formatting adjustments and a revised timestamp.SummaryDifference0.4%
- Check62 days agoChange Detected- Added new topic: Spinal muscular atrophy and updated to revision v3.2.0. - Removed specific term: Proximal spinal muscular atrophy and previous revision v3.1.0.SummaryDifference2%
- Check69 days agoChange DetectedUpdated the page revision from v3.0.2 to v3.1.0, indicating a new software release or update aSummaryDifference0.0%
- Check83 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed.SummaryDifference0.1%
Stay in the know with updates to Nusinersen Safety in SMA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nusinersen Safety in SMA Clinical Trial page.